BACKGROUND:Since their inception in 2000, the Cancer Intervention and Surveillance Network (CISNET) breast cancer models have collaborated to use a nationally representative core of common input parameters to represent key components of breast cancer control in each model. Employment of common inputs permits greater ability to compare model output than when each model begins with different input parameters. The use of common inputs also enhances inferences about the results, and provides a range of reasonable results based on variations in model structure, assumptions, and methods of use of the input values. The common input data are updated for each analysis to ensure that they reflect the most current practice and knowledge about breast c...
The MISCAN-Fadia model was used to analyze the impact of screening and adjuvant treatment on U.S. br...
<p>(See <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111729#pone-0111729-t...
Background External validation of risk models is critical for risk-stratified breast cancer preventi...
In estimating the impact of mammography and adjuvant treatment on U.S. breast cancer mortality rates...
Since 2000, the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (C...
Since 2000, the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (C...
Since 2000, the National Cancer Institute's Cancer Intervention and Surveillance Modeling Network (C...
breast cancer is composed of seven research groups working largely independently to model the impact...
Introduction Breast cancer is the most common cancer and the leading cause of cancer-related death i...
textabstractBackground: Controversy persists about optimal mammography screening strategies. Objecti...
Background: Controversy persists about optimal mammography screening strategies. Objective: To evalu...
BACKGROUND: We used modeling techniques to assess the relative and absolute contributions of screeni...
Background: There are no publicly available tools designed specifically to assist policy makers to m...
Background: OncoSim-Breast is a Canadian breast cancer simulation model to evaluate breast cancer in...
We employed a semi-Markov multistate model for the simultaneous analysis of various endpoints descri...
The MISCAN-Fadia model was used to analyze the impact of screening and adjuvant treatment on U.S. br...
<p>(See <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111729#pone-0111729-t...
Background External validation of risk models is critical for risk-stratified breast cancer preventi...
In estimating the impact of mammography and adjuvant treatment on U.S. breast cancer mortality rates...
Since 2000, the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (C...
Since 2000, the National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (C...
Since 2000, the National Cancer Institute's Cancer Intervention and Surveillance Modeling Network (C...
breast cancer is composed of seven research groups working largely independently to model the impact...
Introduction Breast cancer is the most common cancer and the leading cause of cancer-related death i...
textabstractBackground: Controversy persists about optimal mammography screening strategies. Objecti...
Background: Controversy persists about optimal mammography screening strategies. Objective: To evalu...
BACKGROUND: We used modeling techniques to assess the relative and absolute contributions of screeni...
Background: There are no publicly available tools designed specifically to assist policy makers to m...
Background: OncoSim-Breast is a Canadian breast cancer simulation model to evaluate breast cancer in...
We employed a semi-Markov multistate model for the simultaneous analysis of various endpoints descri...
The MISCAN-Fadia model was used to analyze the impact of screening and adjuvant treatment on U.S. br...
<p>(See <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111729#pone-0111729-t...
Background External validation of risk models is critical for risk-stratified breast cancer preventi...